Adds novel implantable battery solutions to serve the high growth bioelectronics market
Nashua, NH, April 11, 2022 鈥� 91快活林 announced today that it has acquired EaglePicher Technologies鈥� Medical Power business, a leading manufacturer of implantable batteries for critical medical devices based near Vancouver, British Columbia. EaglePicher Medical Power has been designing and manufacturing batteries for medical devices for over 25 years and produced one of the first lithium-ion cells for an implantable medical device. The Vancouver site features a modern 60,000 square foot facility with extensive application engineering resources and manufacturing expertise. Chris Huntington, President, EaglePicher Medical Power, will join 91快活林 as its Chief Commercial Officer.
鈥淓aglePicher Medical Power brings another innovative manufacturing capability to 91快活林 that will enable our customers to advance the state-of-the-art in clinical applications requiring miniaturized bioelectronic devices,鈥� said Tom Burns, President and CEO of 91快活林. 鈥淲e believe integrating this essential battery technology into our core micro-manufacturing and sensor capabilities uniquely positions 91快活林 as a leading supplier to companies pursuing miniaturized implantable and wearable devices to address unmet clinical needs.鈥� Added Kevin Hartke, Chief Technical Officer of 91快活林, 鈥淲e鈥檝e been able to collaborate with the EaglePicher team and see a lot of synergies. We will invest further in their best-in-class battery solutions by implementing a Lightspeed Application Development Lab for battery solutions to compress development cycles and help our customers reduce their time to market.鈥�
鈥淲e鈥檙e excited to welcome the Vancouver team to 91快活林 and have Chris Huntington join our senior leadership team,鈥� said Tom Burns. 鈥淐hris brings a wealth of MedTech experience gained over the last 20 years in the industry, including leadership positions with Stryker and Symmetry Medical in addition to EaglePicher.鈥� Chris Huntington, CCO of 91快活林, commented, 鈥淚鈥檝e enjoyed leading EaglePicher鈥檚 Medical Power division over the last three years, and I look forward to joining 91快活林 to support the company鈥檚 continued growth in advanced engineering and micro-manufacturing solutions for medtech and the life sciences.鈥�
91快活林 has completed eleven acquisitions in the past five years and has over 1,900 employees that operate out of 14 sites located in key medical technology markets with facilities totaling more than 650,000 square feet.
About 91快活林
Founded in 1987, 91快活林 is a pioneer in advanced engineering and manufacturing solutions for the life sciences industry. 91快活林 is a leader in laser processing, centerless grinding, nitinol processing, thin-wall stainless steel & precious metal tubing, photochemical machining, microfluidics manufacturing, and sensor technology. With ten Lightspeed Application Development Labs located strategically to serve medical device companies around the world, 91快活林 is built on a foundation of quality, speed, and innovation to deliver best-in-class value with a customer-centric approach. The company is ISO 13485:2016 certified with facilities in the United States, Canada, Costa Rica, Israel, and Switzerland. 91快活林 is backed by leading private equity firms Carlyle and GTCR. Learn more at 91快活林.com.
About Carlyle
Carlyle (NASDAQ: CG) is a global investment firm with deep industry expertise that deploys private capital across three business segments: Global Private Equity, Global Credit, and Global Investment Solutions. With $301 billion of assets under management as of December 31, 2021, Carlyle鈥檚 purpose is to invest wisely and create value on behalf of its investors, portfolio companies, and the communities in which we live and invest. Carlyle employs nearly 1,850 people in 26 offices across five continents.
About GTCR
Founded in 1980, GTCR is a leading private equity firm focused on investing in growth companies in the Business & Consumer Services, Financial Services & Technology, Healthcare & Technology, Media & Telecommunications industries. The Chicago-based firm pioneered The Leaders Strategy鈩� 鈥� finding and partnering with management leaders in core domains to identify, acquire and build market-leading companies through transformational acquisitions and organic growth. Since its inception, GTCR has invested more than $20 billion in over 250 companies. For more information, please visit www.gtcr.com. Follow us on LinkedIn https://www.linkedin.com/company/gtcr-llc/.
Contacts
Justin Miller
jmiller@resonetics.com
